Cytokinetics launches real-world study of heart drug MYQORZO
AI Summary
Cytokinetics launched a real-world study of MYQORZO, its heart drug. The brief does not specify the study design, participant numbers, or expected timeline.
Cytokinetics launched a real-world study of MYQORZO, its heart drug. The brief does not specify the study design, participant numbers, or expected timeline.
Investing.com —
Globo —
South China Morning Post —
Globo —
Globo —
Harrisburg Patriot-News —